Welcome to our dedicated page for Sabra Health Care Reit news (Ticker: SBRA), a resource for investors and traders seeking the latest updates and insights on Sabra Health Care Reit stock.
Sabra Health Care REIT Inc (SBRA) is a leading healthcare-focused real estate investment trust specializing in nursing facilities, assisted living communities, and behavioral health properties. This page provides investors with a centralized hub for all official company announcements and market-related developments.
Access timely updates on earnings reports, property acquisitions, and strategic partnerships that shape SBRA's position in healthcare real estate. The curated news collection enables stakeholders to track operational milestones, leasing activity, and industry trends impacting this specialized REIT.
Content spans quarterly financial disclosures, facility portfolio expansions, management updates, and regulatory developments. Bookmark this resource to stay informed about SBRA's role in serving healthcare operators through essential real estate solutions across the United States.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that Moody's Ratings has affirmed Sabra's Ba1 credit rating and upgraded its outlook from 'Stable' to 'Positive' on October 17, 2024. This upgrade is attributed to improving industry fundamentals in skilled nursing and senior housing sectors, which are driving enhancements in Sabra's key credit metrics, particularly its net debt to EBITDA ratio. The positive outlook reflects Moody's confidence in Sabra's financial performance and industry positioning. Investors can access the full Moody's report on the rating agency's website for more detailed information about this credit assessment.
Sabra Health Care REIT (Nasdaq: SBRA) has announced the date for its 2024 third quarter earnings release. The company will issue the earnings report on October 31, 2024, after the close of trading. A conference call and simultaneous webcast to discuss the results will be held on Friday, November 1 at 10:00 a.m. Pacific Time.
For those interested in participating, the dial-in number for U.S. participants is 888-880-4448, while participants outside the U.S. can dial 646-960-0572. The conference ID number is 1382596. The webcast can be accessed at https://events.q4inc.com/attendee/444925126. A digital replay of the call will be available on Sabra's website at www.sabrahealth.com.
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has announced its participation in several upcoming industry conferences. Rick Matros, CEO, along with other executives, will attend the INVEST Conference in Dallas from October 7-9, 2024. Talya Nevo-Hacohen, Chief Investment Officer, will participate in the AHCA/NCAL 75th Annual Convention & Expo in Orlando from October 7-8, 2024, speaking on an Investment Solutions panel.
Nevo-Hacohen and Peter Nyland, EVP of Asset Management, will attend the ABI Health Care Program in Nashville from October 8-9, 2024, with Nevo-Hacohen participating in a Hot Topics in Health Care panel. Lastly, Nyland and Armand Markarian, Senior Associate of Asset Management, will attend VERGE 24 in San Jose on October 29-30, 2024.
Sabra Health Care REIT (Nasdaq: SBRA) has announced its participation in two upcoming industry conferences. The company's leadership team, including Talya Nevo-Hacohen (Chief Investment Officer), Darrin Smith (Executive VP of Investments), and Eliza Gozar (Senior VP of Investments), will attend the 2024 NIC Fall Conference from September 23-25 at the Marriott Marquis in Washington, D.C.
Additionally, Rick Matros (Chair and CEO), Michael Costa (CFO), along with Nevo-Hacohen and Smith, will participate in the Virtual Mizuho REIT Conference on October 1-2, 2024. These events provide Sabra Health Care REIT with opportunities to engage with industry peers, investors, and analysts, potentially impacting the company's visibility and stock performance.
Sabra Health Care REIT (Nasdaq: SBRA) has announced its participation in the BofA Securities 2024 Global Real Estate Conference. The event is scheduled for September 10, 2024, at the Bank of America Tower in New York City. Key executives from Sabra will be in attendance, including:
- Rick Matros - Chair and CEO
- Michael Costa - CFO
- Talya Nevo-Hacohen - CIO
- Darrin Smith - Executive VP of Investments
- Lukas Hartwich - Senior VP of Finance
This conference provides an opportunity for Sabra to engage with investors and industry professionals, potentially discussing their real estate investment strategies and market outlook in the healthcare sector.
Sabra Health Care REIT (Nasdaq: SBRA) reported strong Q2 2024 results, prompting an increase in 2024 guidance. Key highlights include:
- Net Income per share: $0.10
- FFO per share: $0.35
- AFFO per share: $0.36
- Same store managed senior housing Cash NOI increased 17.7% year-over-year
- Investment activity of $60.1 million with 8.7% expected initial cash yield
- Net Debt to Adjusted EBITDA: 5.45x
- Quarterly cash dividend declared: $0.30 per share
The company increased its 2024 guidance, with Normalized AFFO now expected to be $1.41 - $1.44 per diluted share. Positive reimbursement trends, including a 4.2% Medicare rate increase for skilled nursing facilities and an estimated 7% average increase in Medicaid rates across Sabra's portfolio, contribute to the improved outlook.
Sabra Health Care REIT (Nasdaq: SBRA) has released its fourth annual Sustainability Report for fiscal year 2023, highlighting its commitment to environmental, social, and governance (ESG) initiatives. The report showcases Sabra's progress in areas such as environmental stewardship, diversity and inclusion, human capital management, and community service.
Key achievements include:
- Expanded utility data collection to 100% of managed portfolio
- Embedded E-Initiative awareness across asset management team
- Assembled resources to support Healthtech solutions
- Upheld commitment to diversity, equity, and inclusion
Sabra's CEO, Rick Matros, emphasized the alignment between business strategy and sustainability initiatives, stating that these efforts are important for creating long-term value for stakeholders.
Sabra Health Care REIT (Nasdaq: SBRA) has announced the schedule for its 2024 second quarter earnings release and conference call. The company will release its earnings report on August 7, 2024, after the market closes. A conference call and simultaneous webcast to discuss the results will be held on Thursday, August 8 at 10:00 a.m. Pacific Time.
Investors can participate in the call using the following details:
- U.S. participants: 888-880-4448
- International participants: 646-960-0572
- Conference ID: 1382596
Sabra Health Care REIT (Nasdaq: SBRA) has announced that key executives including CEO Rick Matros, CFO Michael Costa, CIO Talya Nevo-Hacohen, CAO Jessica Flores, and SVP of Finance Lukas Hartwich will participate in Nareit’s REITweek 2024 Investor Conference. This event will be held from June 4 to June 6, 2024, at the New York Hilton Midtown in New York City.
The participation in this conference signals SBRA's commitment to engaging with investors and stakeholders, presenting an opportunity to discuss company strategies, financial health, and future plans. The conference is a significant event within the REIT community, drawing attention from a broad range of investors and industry analysts.
Sabra Health Care REIT, Inc. announced its first-quarter 2024 results, reporting positive earnings per diluted common share figures. The company reiterates its 2024 guidance, showcasing strong financial performance and a solid balance sheet. Sabra's CEO highlighted the portfolio's growth and strength, emphasizing a positive outlook for future investments. The company also disclosed its liquidity status and upcoming conference call details.